[Primary angioplasty in acute myocardial infarct. A report on 304 consecutive patients]

J M García y Otero1, E Frutos Rangel, R García García

  • 1Departamento de Cardiología, Hospital del Carmen, Guadalajara, Jalisco, México.

Archivos Del Instituto De Cardiologia De Mexico
|November 12, 1998
PubMed

Insights

Primary percutaneous coronary angioplasty (PTCA) is a successful treatment for acute myocardial infarction, achieving high success rates and low mortality, even in high-risk patients. This study details a single-center experience with 304 patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Context:

  • Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide.
  • Timely reperfusion therapy is critical for improving outcomes in AMI.
  • Primary percutaneous coronary angioplasty (PTCA) is a key reperfusion strategy.

Purpose:

  • To report the single-center experience with primary PTCA in 304 consecutive patients with AMI.
  • To evaluate the procedural success and in-hospital outcomes of primary PTCA.
  • To assess the safety and efficacy of primary PTCA in a real-world patient cohort.

Summary:

  • The study included 304 AMI patients (67% male, mean age 69 years) treated with primary PTCA.
  • Key findings include a mean onset-to-treatment time of 3.5 hours, 14% prior bypass surgery, 23% prior MI, and 11% in cardiogenic shock.
  • Procedural success was 95% with an in-hospital mortality of 6.5%, demonstrating effectiveness even in high-risk subgroups.

Impact:

  • Primary PTCA is confirmed as an effective reperfusion strategy for acute myocardial infarction.
  • The findings support the use of primary PTCA in diverse patient populations, including those with high-risk features.
  • This study contributes to the evidence base for primary PTCA, showing comparable success and complication rates to published data.